Dr Frederick Oliver Buckley Jr, MD | |
104 Endicott St, Suite 200, Danvers, MA 01923-3623 | |
(978) 882-6868 | |
(978) 882-6828 |
Full Name | Dr Frederick Oliver Buckley Jr |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 104 Endicott St, Danvers, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013905025 | NPI | - | NPPES |
2071843 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 44363 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Frederick Oliver Buckley Jr, MD 104 Endicott St, Suite 200, Danvers, MA 01923-3623 Ph: (978) 882-6868 | Dr Frederick Oliver Buckley Jr, MD 104 Endicott St, Suite 200, Danvers, MA 01923-3623 Ph: (978) 882-6868 |
News Archive
The hygiene hypothesis may explain why asthma and other allergic airway diseases have dramatically increased over the past decades in industrialized countries.
In the current issue of Cardiovascular Innovations and Applications volume 4, issue 1, pp. 71-75(5); DOI https://doi.org/10.15212/CVIA.2017.0076, Robert F. Hamburger, DO, MPH, FACC, from the Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, FL, USA and Malcom Randall VA Medical Center, Gainesville, FL, USA considers adult congenital heart disease in the veteran population.
Janssen-Cilag International NV, today announced it has submitted a Marketing Authorisation Application to the European Medicines Agency seeking approval for a once-daily single tablet fixed-dose antiretroviral combination product containing darunavir, a protease inhibitor developed by Janssen, with cobicistat, a pharmacokinetic enhancer or boosting agent, developed by Gilead Sciences, Inc. for use in combination with other human immunodeficiency virus medicines.
The American Red Cross today issued an appeal for blood donors to roll up a sleeve and address a critical shortage across the nation.
Oraya Therapeutics, Inc. today announced that one of the patients who successfully was treated for wet age-related macular degeneration (AMD) with Oraya Therapy during the INTREPID clinical trial has released data showing he has experienced significant, sustained vision improvement more than two years after treatment in his right eye, without any subsequent anti-vascular endothelial growth factor (anti-VEGF) injections or other treatment.
› Verified 2 days ago
Vinod Narra, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 104 Endicott St Ste 200, Danvers, MA 01923 Phone: 978-882-6375 Fax: 978-882-6517 | |
Dr. William Vasilos Kastrinakis, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 104 Endicott St, Suite 200, Danvers, MA 01923 Phone: 978-882-6868 Fax: 978-882-6828 | |
Mr. Larry Philip Goldberg, MD Surgery Medicare: Medicare Enrolled Practice Location: 104 Endicott St, Suite 200, Danvers, MA 01923 Phone: 978-882-6868 Fax: 978-882-6855 | |
Dr. Russell Lloyd Ranson Ryan, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 104 Endicott St, Suite 200, Danvers, MA 01923 Phone: 978-882-6868 Fax: 978-882-6855 | |
David J Martini, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 104 Endicott St, Suite 200, Danvers, MA 01923 Phone: 978-882-6899 Fax: 978-882-6890 | |
Dr. Jaime Alfredo Rivera, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 104 Endicott St, Suite 200, Danvers, MA 01923 Phone: 978-882-6868 Fax: 978-882-6855 |